Health Administration

In Modernizing Medicare, editors Robert Emmet Moffit and Marie Fishpaw bring together a rare combination of leading scholars and policy practitioners to outline a vision for Medicare reform and provide solutions for the millions of seniors whose health care depends on it. Contributors include a former Medicare trustee, a former Medicare administrator, and a former director of the Congressional Budget Office.

Covid is a viral infection that the human race has not seen before, but has become much more intriguing than just that. It may be the first pandemic from a genetically modified virus. The vaccine is also a mRNA derived vaccine, one never before used in the general population and has properties that are unlike the antibody protection from our usual vaccines or natural infections.

On May 3, 2006, Ted Giovanis emailed a US government official, seeking clarity on an arcane issue: the calculation used by Medicare to determine reimbursement rates for certain kinds of hospitals. Though he expected a routine exchange, what unfolded was anything but.

“Leading Healthcare Transformation: Doctors, Nurses, and Managers at the Helm” is an exhaustive analysis of the modern dynamics in the healthcare sector, with a particular emphasis on middle management leadership. It provides a deep dive into the roles, responsibilities, and leadership abilities required by different professionals, including doctors, nurses, and managers.

While the War on Drugs may have sounded like a good idea at one time, the consequences have been catastrophic. From physicians persecuted for providing health care to their patients to parents grieving the loss of their children to overdose or prison - we've all become victims of this war. Our health, our families, our assets, our safety and our freedom are at risk: One in three adults in the U.S. now has a criminal record. In War on Us, Colleen Cowles raises the alarm and offers practical, proven reforms.

Government, industry, and the medical profession, however, have a mixed record when it comes to framing policies and generating knowledge to address drug use and misuse. In Strange Trips, Lucas Richert investigates the myths, meanings, and boundaries of recreational drugs, palliative care drugs, and pharmaceuticals as well as struggles over product innovation, consumer protection, and freedom of choice in the medical marketplace.

Challenging Operations takes up the apparent paradox of medical professionals resisting reforms designed to help them and their patients. Through vivid anecdotes, interviews, and incisive observation and analysis, Katherine Kellogg reveals the complex ways that institutional reforms spark resistance when they challenge long-standing beliefs, roles, and systems of authority. Shedding new light on the difficulty of implementing reforms, Challenging Operations offers concrete recommendations for effectively meeting that challenge.

Life and Death in Intensive Care offers a unique portrait of the surgical intensive care unit (SICU), the place in medical centers and hospitals where patients with the gravest medical conditions - from comas to terminal illness - are treated. Author Joan Cassell employs the concept of moral economies to explain the dilemmas that patients, families, and medical staff confront in treatment.

With the rise of the Movement for Black Lives and the feverish calls for Medicare for All, the public spotlight on racial inequality and access to healthcare has never been brighter. Just Health examines how deep structural racism embedded leads to worse health outcomes and lower life expectancy for people of color. By presenting evidence of discrimination in housing, education, employment, and the criminal justice system, Dayna Bowen Matthew shows how racial inequality pervades American society and the ways that this undermines the health of minority populations.

Stoppt das Krankenhaussterben! Krankenhäuser in Deutschland und Europa sind längst zum Spekulationsobjekt international agierender, privater Klinikkonzerne geworden. Die Folge: Die Konzerne erzielen Renditen aus dem solidarischen System unseres Gesundheitswesens. Thomas Strohschneider war selbst jahrelang als Chefarzt in einer privatwirtschaftlich geführten Klinik tätig.

Es imposible calcular el alcance exacto de la crisis del Coronavirus en nuestra economía, salud y forma de vida a partir de ahora. Lo único que sabemos es que salimos a un mundo distinto al que hemos conocido, y eso no tiene que ser necesariamente malo. Para vivir esta nueva era llena de desafíos, 20 maestros nos dan, cada cual desde su campo, un kit de supervivencia para vivir de forma proactiva, optimista y sin miedo.

For African Americans in the southern United States, the social determinants of health are influenced by a unique history that encompasses hundreds of years of slavery, injustices during the Jim Crow era, the Great Migration, the civil rights era, and contemporary experiences like the Black Lives Matter movement. Black activists, physicians, and communities continue to battle inequities and structural problems that include poverty, inadequate access to health care, incarceration, a lack of transportation, and food insecurity.

In My Quest for Health Equity, Dr. Satcher takes an inspiring and instructive look inside his fifty-year career to shed light on the challenge and burden of leadership. Explaining that he has thought of each leadership role—whether in academia, community, or government—as an opportunity to move the needle toward health equity, he shares the hard-won lessons he has learned over a lifetime in the medical field.

Philip Moeller has written a reliable, concise guide to health care and health insurance basics. He provides tools that patients need before, during, and after they get medical care. He describes the care we need, the care we don’t, and how to deal with doctors, hospitals, and other health-care providers. Moeller explains telemedicine and health-care apps that have become so important during the coronavirus epidemic. The book shares the stories of disruptive health innovators who have given us access to true health costs, cheaper prescription drugs, and low-cost care.

Ezekiel J. Emanuel, a professor of medical ethics and health policy at the University of Pennsylvania who also served as a special adviser to the White House on health-care reform, has written a brilliant diagnostic explanation of why health care in America has become such a divisive social issue, how money and medicine have their own American story, and why reform has bedeviled presidents of the left and right for more than one hundred years.

The inside story of the most audacious public health campaign of the 21st century. In 2002, a dynamic doctor named Thomas Frieden became health commissioner of New York City. With support from the new mayor, billionaire Michael Bloomberg, Frieden and his health department team prohibited smoking in bars, outlawed trans fats in restaurants, and attempted to cap the size of sodas, among other groundbreaking actions.

With technological advances and information sharing so prevalent, health care should be more transparent and easier to access than ever before. So why does it seem like everything about it - from pricing, drug development, and the emergence of new diseases to the intricacies of biologic and precision medicine therapies - is becoming more complex, not less?

Over the past three decades, the once-efficient American health care system has evolved into a complex maze of monopolies and a racket of bureaucratic checks, approvals, denials, roadblocks, and detours. This shift has created a massive and at times redundant workforce that frustrates patients, as well as physicians, nurses, and administrative staff. Health care costs the United States more than $11,000 for each person in the country each year - more than double what it costs in most Western European countries to deliver equal or even better care.

For decades, researchers have chased a pharmaceutical cure for memory loss. But despite the fact that no disease-modifying biotech treatments have emerged, new research suggests that dementia rates have actually declined in the United States and Western Europe over the last decade. Why is this happening? And what does it mean for brain health in the future?

Our health care system is crippled by desperate efforts to prevent the inevitable. A third of the national Medicare budget - nearly $175 billion - is spent on the final year of life, and a third of that amount on the final month, often on expensive (and futile) treatments. Such efforts betray a fundamental flaw in how we think about healthcare: we squander resources on hopeless situations, instead of using them to actually improve health.